Phillip Frost owns 15% of MBVX so (hopefully) he's right on this one.
Looking forward to the Phase I update. Having lost close family members to pancreatic cancer, I'm hopeful their immuno-oncology research turns out to bring some positives- either in treatment or imaging improvements.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.